|
⚲
|
| Keyboard |
| Martens Rachel Yap
✚
|
|
|---|---|
| CIK # | 0002071589 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002071589] | |
| 4 | [0002071589] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Martens Rachel Yap | |
| Lexicon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Tax withheld | 35,826 | $1.47 | 52,664 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Option exercise | 67,090 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-28 | Option exercise | 67,090 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2026-02-12 | Grant | 290,620 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-12 | Grant | 193,740 | $0.00 |